Cartesian Therapeutics secures loan financing from K2 HealthVentures
Cartesian Therapeutics entered into a Loan and Security Agreement with K2 HealthVentures LLC as lender and administrative agent, dated May 22, 2026. The financing arrangement provides debt capital for the biopharmaceutical company's operations and development activities.
View filing at SEC.gov →